Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer
CheckMate 017 和 057 随机 III 期试验的五年结果：纳武利尤单抗与多西他赛治疗既往接受过治疗的非小细胞肺癌
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.20.01605
Borghaei, Hossein; Gettinger, Scott; Vokes, Everett E; Chow, Laura Q M; Burgio, Marco Angelo; de Castro Carpeno, Javier; Pluzanski, Adam; Arrieta, Oscar; Frontera, Osvaldo Arén; Chiari, Rita; Butts, Charles; Wójcik-Tomaszewska, Joanna; Coudert, Bruno; Garassino, Marina Chiara; Ready, Neal; Felip, Enriqueta; García, Miriam Alonso; Waterhouse, David; Domine, Manuel; Barlesi, Fabrice; Antonia, Scott; Wohlleber, Markus; Gerber, David E; Czyzewicz, Grzegorz; Spigel, David R; Crino, Lucio; Eberhardt, Wilfried Enst Erich; Li, Ang; Marimuthu, Sathiya; Brahmer, Julie
